A CU Medicine provider.

I believe that there is no “one-size fits all” approach in medicine, especially with cancer therapy. I strive to use the best scientific principles available and tailor these to the individual needs and circumstances of each patient.

I am interested in targeted therapies and novel biomarkers. My true passion outside of medicine is classical piano performance. I also dabble with sketch comedy, film, and skiing on the side.

Locations

Monday: 8am - 4:30pm
Tuesday: 8am - 4:30pm
Wednesday: 8am - 4:30pm
Thursday: 8am - 4:30pm
Friday: 8am - 4:30pm
Saturday: Closed
Sunday: Closed
Monday: 8am - 5pm
Tuesday: 8am - 5pm
Wednesday: 8am - 5pm
Thursday: 8am - 5pm
Friday: 8am - 5pm
Saturday: Closed
Sunday: Closed

Qualifications and experience

Specialties
Hematology and Oncology, Internal Medicine, Cancers - Lung Cancer, Cancers, Cancers - Cancer Medicine
Gender
Male
Languages spoken
Education
Internship
University of Colorado (2013)

Fellowship
University of Colorado (2020)

Medical School
Keck School of Medicine of the University of Southern California (2013)

Residency
University of Colorado (2016)

Undergraduate
University of Pennsylvania (Philadelphia, PA) (2007)

Clinical interest for patients

My clinical and research interests include: (1) molecular diagnostics in lung cancer, (2) managing acquired resistance to targeted therapies (such as ALK, EGFR, ROS1 tyrosine kinase inhibitors), and (3) developing rational combinations of therapies based on evolutionary and molecular biology. I am also interested in novel clinical trials that address unmet needs among our patients with lung cancer.

Research interest for patients

My research interests are in precision oncology, biomarker testing and development, targeted therapies, and characterizing acquired resistance to cancer therapies.

Insurance
UCHealth strongly encourages you to consult with your health insurer to determine accurate information about your coverage and benefits for a particular health care service provided at a UCHealth facility. Read more here.